Treatment of advanced small cell lung cancer. Clinical case and literature review
Lung cancer is one of the most common tumors in humans. The incidence is in one of the leading positions. In 2019 1327 patients with this pathology were identified in the Republic of Bashkortostan. Of these, with stage III of the disease 28.7%, with stage IV 45.8%, which is higher. Small cell lung...
Guardado en:
Autores principales: | Konstantin V. Menshikov, Aleksandr V. Sultanbaev, Shamil I. Musin, Irina A. Menshikova, Ainur F. Nasretdinov, Nadezda I. Sultanbaeva |
---|---|
Formato: | article |
Lenguaje: | RU |
Publicado: |
IP Habib O.N.
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/84b8fb205d4b4a0d9e375fb79bab01f4 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Retrospective analysis of outcomes and prognostic factors of chemotherapy for small-cell lung cancer
por: Minami S, et al.
Publicado: (2016) -
New PD-L1 inhibitors in non-small cell lung cancer – impact of atezolizumab
por: Seetharamu N, et al.
Publicado: (2017) -
Immunohistochemistry for Thymidine Kinase-1 (TK1): A Potential Tool for the Prognostic Stratification of Breast Cancer Patients
por: Giuseppe Nicolò Fanelli, et al.
Publicado: (2021) -
Prognostic role of clinical and biological factors and parameters of hormonal profile in patients with primary inoperable HER2-negative breast cancer
por: Natalia I. Samaneva, et al.
Publicado: (2021) -
Clinical Outcomes of Chemotherapeutic Molecules as Single and Multiple Agents in Advanced Non-Small-Cell Lung Carcinoma (NSCLC) Patients
por: Ting Yoon Kwan, et al.
Publicado: (2021)